Last reviewed · How we verify
NCT05865639
Time Restricted Fasting and Aerobic Exercise Interventions Among Sedentary Adults
NA trial testing Aerobic Exercise in Sedentary; Aging in 56 participants. Completed in 1 December 2022.
1 September 2022
Quick facts
| Lead sponsor | Guangzhou Sport University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 56 |
| Start date | 1 February 2022 |
| Primary completion | 1 September 2022 |
| Estimated completion | 1 December 2022 |
| Sites | 1 location across China |
Drugs / interventions tested
- Aerobic Exercise — full drug profile →
- Time Restricted Fasting
Conditions studied
- Sedentary; Aging — all drugs for Sedentary; Aging →
Sponsor
Guangzhou Sport University
Who can join
Adults 45 to 69, any sex, with Sedentary; Aging. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project will determine the independent and combined effects of aerobic exercise and time restricted fasting on cardiovascular risks among sedentary middle-aged and elderly adults. The online intervention period will be eight weeks. Before and after the intervention, arterial stiffness, cardiac autonomic nervous, body composition, glucolipid metabolism, sleep and eating habits, inflammatory reaction, sedentary behavior and physical activity level will be measured and compared between groups who are doing either aerobic exercise, time restricted fasting, both aerobic exercise and time restricted fasting, or who are in a control group. Adverse reaction, sleep and eating quality, life quality and adherence to the interventions and hunger/satiety will also be measured.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Effects of Time-Restricted Feeding and Exercise on Cardiometabolic Health in Sedentary Older Adults: A Randomized Controlled Trial.
Peng L, Chen L, Xia J, Zhou J, et al · · 2026 · PMID 41806970 · DOI 10.1249/mss.0000000000003962
Verify or expand the search:
- PubMed search for NCT05865639
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Aerobic Exercise
Trials testing the same drug.
- NCT07517224 — Assessing the Effect of an Aerobic Exercise Program on Vascular Function in Women With Non-Metastatic Breast Cancer · NA · not yet recruiting
- NCT07444333 — Cardiac Output and Fatigue in Friedreich's Ataxia · NA · not yet recruiting
- NCT07182006 — Exercise as Medicine for Pediatric Chronic Pain · NA · not yet recruiting
- NCT07404319 — Effectiveness of Exercise Alone and tDCS+Exercise on Cognitive Function Improvement in Patients With Treatment Resistant · NA · not yet recruiting
- NCT07302204 — Efficacy of Aerobic Exercise Versus Therapeutic Exercises on Exercise-induced Hypoalgesia in Knee Osteoarthritis · NA · recruiting
Other Guangzhou Sport University trials
Trials by the same sponsor.
- NCT05650983 — Effect of Exercise on Cognitive Function and Mental Health in Heroin Addicts · NA · completed
- NCT03762629 — Exercise and Diet Restriction on Cardiovascular Function in Obese Children and Adolescents · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05865639 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Guangzhou Sport University
- Last refreshed: 19 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05865639.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing